Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neural Transmission
Metadata
Title
Alzheimer's vaccine: a cure as dangerous as the disease?
Authors
G. Münch
S. R. Robinson
Publication date
01-04-2002
Publisher
Springer-Verlag
Published in
Journal of Neural Transmission / Issue 4/2002
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s007020200044

Other articles of this Issue 4/2002

Journal of Neural Transmission 4/2002 Go to the issue

OriginalPaper

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa

OriginalPaper

Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats

OriginalPaper

Steele-Richardson-Olszewski-Syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI

OriginalPaper

Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice

OriginalPaper

The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells

OriginalPaper

Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease